Applied DNA Sciences (APDN) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall Street futures subdued as tech wobbles again; Tesla gains
- Oil heads for weekly gain with focus on Middle East supply
- U.S. producer prices rise by 1.3% month-on-month in September
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Net loss before provision for income taxes: -2.42M
Today's EPS Names:
OMID, BCBP, BCML, More
Financial Fact:
Net loss before provision for income taxes: -2.42M
Today's EPS Names:
OMID, BCBP, BCML, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $778 thousand versus the consensus estimate of $1.32 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rosenblatt cautious on Netflix (NFLX), sees studios and NFLX not wanting to discuss 'genAI can radically reduce content cost structures'
- Top healthcare stocks to watch: TD Cowen’s latest picks
- Travelers (TRV) Tops Q3 EPS by $1.93, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
